[1]李 桃.泮托拉唑、克拉霉素、阿莫西林与果胶铋四联疗法不同疗程治疗胃溃疡临床疗效的比较研究[J].医学信息,2025,38(09):121-124.[doi:10.3969/j.issn.1006-1959.2025.09.024]
　LI Tao.Comparative Study on the Clinical Efficacy of Pantoprazole, Clarithromycin, Amoxicillin and Bismuth Pectin Quadruple Therapy with Different Courses in the Treatment of Gastric Ulcer[J].Journal of Medical Information,2025,38(09):121-124.[doi:10.3969/j.issn.1006-1959.2025.09.024]
点击复制

泮托拉唑、克拉霉素、阿莫西林与果胶铋四联疗法不同疗程治疗胃溃疡临床疗效的比较研究()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年09期
页码:
121-124
栏目:
论著
出版日期:
2025-05-01

文章信息/Info

Title:
Comparative Study on the Clinical Efficacy of Pantoprazole, Clarithromycin, Amoxicillin and Bismuth Pectin Quadruple Therapy with Different Courses in the Treatment of Gastric Ulcer
文章编号:
1006-1959（2025）09-0121-04
作者:
李 桃
信丰县中医院消化内科，江西 信丰 341600
Author(s):
LI Tao
Department of Gastroenterology, Xinfeng County Hospital of Traditional Chinese Medicine, Xinfeng 341600, Jiangxi, China
关键词:
胃溃疡; 四联疗法; 泮托拉唑; 克拉霉素; 阿莫西林; 果胶铋
Keywords:
Gastric ulcer: Quadruple therapy;  Pantoprazole;  Clarithromycin;  Amoxicillin;  Pectin bismuth
分类号:
R573.1
DOI:
10.3969/j.issn.1006-1959.2025.09.024
文献标志码:
A
摘要:
目的 探究不同疗程的四联疗法（泮托拉唑+克拉霉素+阿莫西林+果胶铋）治疗胃溃疡的临床效果。方法 选取2020年11月-2023年11月信丰县中医院收治的68例胃溃疡患者，经随机数字表法分为常规组（34例）与延长组（34例）。两组均采用四联疗法（泮托拉唑+克拉霉素+阿莫西林+果胶铋），常规组治疗时长2周，延长组在其基础上延长泮托拉唑与果胶铋的用药时长1周，比较两组临床疗效、症状变化（胃灼烧痛、腹胀、恶心）、胃溃疡愈合时间、不良反应、复发情况（治疗后3个月）。结果 延长组治疗有效率高于常规组（P＜0.05）。两组治疗后症状积分（胃灼烧痛、腹胀、恶心）低于治疗前，且延长组症状积分（胃灼烧痛、腹胀、恶心）低于常规组（P＜0.05）。延长组胃溃疡愈合时间短于常规组，复发率低于常规组（P＜0.05）。两组不良反应发生率对比，差异无统计学意义（P＞0.05）。结论 四联疗法（泮托拉唑+克拉霉素+阿莫西林+果胶铋）治疗胃溃疡效果确切，在常规疗程基础上延长泮托拉唑与果胶铋治疗时长，可提高其临床疗效，促进症状改善，加速病情转归，降低胃溃疡的复发风险，且不增加患者的不良反应。
Abstract:
Objective To explore the clinical effect of different courses of quadruple therapy (pantoprazole+clarithromycin+amoxicillin+bismuth pectin) in the treatment of gastric ulcer. Methods A total of 68 patients with gastric ulcer admitted to Xinfeng County Hospital of Traditional Chinese Medicine from November 2020 to November 2023 were selected and divided into routine group (34 patients) and prolonged group (34 patients) by random number table method. Both groups were treated with quadruple therapy (pantoprazole+clarithromycin+amoxicillin+bismuth pectin). The conventional group was treated for 2 weeks, and on the basis of the conventional group, the extension group extended the duration of pantoprazole and bismuth pectin for 1 week. The medication time of pantoprazole and bismuth pectin was 1 week. The clinical efficacy, symptom changes (heartburn, abdominal distension, nausea), gastric ulcer healing time, adverse reactions, and recurrence (3 months after treatment) were compared between the two groups. Results The effective rate of treatment in the extended group was higher than that in the conventional group (P<0.05). After treatment, the symptom scores (heartburn, abdominal distension, nausea) of the two groups were lower than those before treatment, and the symptom scores (heartburn, abdominal distension, nausea) of the extended group were lower than those of the conventional group (P<0.05). The gastric ulcer healing time in the extended group was shorter than that in the conventional group, and the recurrence rate was lower than that in the conventional group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion Quadruple therapy (pantoprazole+clarithromycin+amoxicillin+bismuth pectin) is effective in the treatment of gastric ulcer. Prolonging the treatment time of pantoprazole and bismuth pectin on the basis of routine treatment can improve its clinical efficacy, promote the improvement of symptoms, accelerate the outcome of the disease, reduce the risk of recurrence of gastric ulcer, and do not increase the adverse reactions of patients.

参考文献/References:

[1]于涛,于鑫.奥美拉唑联合克拉霉素治疗老年性胃溃疡的效果[J].中国药物滥用防治杂志,2023,29(12):2134-2137.[2]Xiao M,Liu J,Hui J.Analysis of the Effect of Pantoprazole and Omeprazole on Pain Relief in Patients with Gastric Ulcer[J].Journal of Clinical and Nursing Research,2021,5(3):142-145.[3]赵京平,王誉敏,游云龙,等.艾司奥美拉唑联合阿莫西林方案与含铋剂四联方案对幽门螺杆菌感染初治患者的疗效比较[J].实用临床医药杂志,2022,26(12):51-55,60.[4]王聪.四联疗法对不同CYP2C19型幽门螺杆菌相关性胃溃疡患者基质金属蛋白酶和金属蛋白酶组织抑制剂1表达的影响[J].中国药物与临床,2022,22(3):208-211.[5]刘香吉.铋剂四联对胃溃疡患者血清炎性因子、H.pylori根治率及细胞免疫指标的影响[J].河北医药,2021,43(23):3637-3639.[6]汪慧霞,张彩凤,常勇生,等.益生菌联合铋剂四联疗法治疗幽门螺杆菌感染消化性溃疡的疗效分析[J].现代消化及介入诊疗,2021,26(9):1158-1161.[7]王雪艳,张旭东,潘海洋.康复新液联合四联疗法治疗幽门螺旋杆菌阳性胃溃疡的临床研究[J].现代药物与临床,2021,36(8):1613-1618.[8]中华消化杂志编辑委员会.消化性溃疡诊断与治疗共识意见（2022年,上海）[J].胃肠病学,2023,28(4):208-225.[9]罗酩,吴永梅,李文娟,等.四联疗法对幽门螺杆菌相关性胃溃疡的疗效及对胃黏膜形态学的影响[J].山西医药杂志,2021,50(10):1698-1699.[10]任小娇.阿莫西林甲硝唑及雷贝拉唑联合治疗对胃溃疡伴幽门螺杆菌感染疗效与不良反应观察[J].中国药物与临床,2021,21(14):2528-2529.[11]钟雄平.含铋剂四联疗法根除幽门螺杆菌感染的临床疗效分析[J].山西医药杂志,2020,49(19):2645-2646.[12]张莉,叶溪,刘晓霞.奥美拉唑与兰索拉唑及泮托拉唑治疗胃炎胃溃疡的疗效比较[J].中国全科医学,2020,23(1):158-160.[13]朱虹,时昭红,张书,等.含铋剂四联疗法对幽门螺旋杆菌感染患者血清炎性因子及免疫功能的影响[J].中华医院感染学杂志,2020,30(1):77-81.[14]樊文静,张振宇,杨景玉,等.含铋剂四联疗法治疗幽门螺旋杆菌阳性胃溃疡的临床效果[J].广西医学,2019,41(18):2306-2308.[15]汪海涛,夏建新,梅冬雪,等.幽门螺杆菌阳性胃溃疡治疗过程中不同疗程双歧杆菌四联活菌片的效果[J].中国综合临床,2022,38(5):419-424.[16]刘宏伟,黄玉洁,杨剑英,等.铝碳酸镁、兰索拉唑、阿莫西林、呋喃唑酮四联疗法治疗幽门螺杆菌相关性胃溃疡的效果及安全性评价[J].中国综合临床,2020,36(1):22-27.[17]郑长清,张喆.东方胃药联合标准三联疗法与含铋剂四联疗法治疗Hp相关性胃炎及消化性溃疡患者临床疗效对比分析[J].实用药物与临床,2022,25(1):46-50.[18]Leng YZ,Wang HJ,Gao L,et al.Efficacy of pantoprazole plus perforation repair for peptic ulcer and its effect on the stress response[J].World Journal of Gastrointestinal Surgery,2023,15(12):2757-2764.[19]李理总,刘彤,何晓静,等.含质子泵抑制剂的铋剂四联方案根除幽门螺杆菌的成本-效果分析[J].实用药物与临床,2020,23(4):349-352.[20]海花,乌仁图雅,陈金金.“四联”疗法后延长质子泵抑制剂和铋剂治疗对幽门螺杆菌阳性胃溃疡的疗效及安全性分析[J].现代消化及介入诊疗,2020,25(11):1495-1497.[21]李辰,歧红阳,毛建娜,等.胃溃疡患者幽门螺杆菌感染及不同治疗方法临床疗效分析[J].中国病原生物学杂志,2023,18(12):1438-1442.

相似文献/References:

[1]邱君旗.幽门螺杆菌根除治疗对幽门螺杆菌阳性的功能性消化不良患者疗效分析[J].医学信息,2018,31(04):75.[doi:10.3969/j.issn.1006-1959.2018.04.024]
　QIU Jun-qi.Efficacy of Helicobacter Pylori Eradication Therapy in Patients with HP Positive Functional Dyspepsia[J].Journal of Medical Information,2018,31(09):75.[doi:10.3969/j.issn.1006-1959.2018.04.024]
[2]薛守宇,廉 婷,耿爱民.补中益气活血方对胃溃疡患者血清TFF2和SOD水平的影响[J].医学信息,2022,35(10):105.[doi:10.3969/j.issn.1006-1959.2022.10.025]
　XUE Shou-yu,LIAN Ting,GENG Ai-min.Effect of Buzhong Yiqi Huoxue Recipe on Serum Levels of TFF2 and SOD in Patients with Gastric Ulcer[J].Journal of Medical Information,2022,35(09):105.[doi:10.3969/j.issn.1006-1959.2022.10.025]
[3]侯拂晓.四联疗法治疗幽门螺旋杆菌相关性十二指肠球炎疗效分析[J].医学信息,2018,31(17):135.[doi:10.3969/j.issn.1006-1959.2018.17.042]
　HOU Fu-xiao.Therapeutic Effect of Quadruple Therapy on Helicobacter pylori Associated Duodenal Inflammation[J].Journal of Medical Information,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.17.042]
[4]潮子健,汪文生,谢宏伟.年龄对胃部常见良性疾病患者的胃蛋白酶原及胃泌素-17水平的影响[J].医学信息,2018,31(23):105.[doi:10.3969/j.issn.1006-1959.2018.23.028]
　CHAO Zi-jian,WANG Wen-sheng,XIE Hong-wei.Effect of Age on Pepsinogen and Gastrin-17 Levels in Patients with Common Benign Diseases of the Stomach[J].Journal of Medical Information,2018,31(09):105.[doi:10.3969/j.issn.1006-1959.2018.23.028]
[5]朱爱娥,王菊艳.系统护理干预对慢性胃炎及胃溃疡患者临床疗效及生活质量的影响研究[J].医学信息,2019,32(04):188.[doi:10.3969/j.issn.1006-1959.2019.04.063]
　ZHU Ai-e,WANG Ju-yan.Effect of Systematic Nursing Intervention on Clinical Efficacy and Quality of Life in Patients with Chronic Gastritis and Stomach Ulcer[J].Journal of Medical Information,2019,32(09):188.[doi:10.3969/j.issn.1006-1959.2019.04.063]
[6]王晓琼,曾凡玲.体检者胃溃疡检出率及其影响因素分析[J].医学信息,2019,32(23):132.[doi:10.3969/j.issn.1006-1959.2019.23.039]
　WANG Xiao-qiong,ZENG Fan-ling.Analysis of the Detection Rate of Gastric Ulcer and its Influencing Factors in Physical Examination Patients[J].Journal of Medical Information,2019,32(09):132.[doi:10.3969/j.issn.1006-1959.2019.23.039]
[7]魏 明.铝碳酸镁与艾司奥美拉唑联合治疗胃溃疡的疗效[J].医学信息,2021,34(21):109.[doi:10.3969/j.issn.1006-1959.2021.21.029]
　WEI Ming.Effect of Magnesium Aluminate Combined with Esomeprazole in the Treatment of Gastric Ulcer[J].Journal of Medical Information,2021,34(09):109.[doi:10.3969/j.issn.1006-1959.2021.21.029]
[8]谢迎新.复方嗜酸乳杆菌联合常规四联疗法治疗幽门螺旋杆菌感染消化性溃疡的疗效[J].医学信息,2020,33(02):138.[doi:10.3969/j.issn.1006-1959.2020.02.040]
　XIE Ying-xin.Effect of Compound Lactobacillus Acidophilus Combined with Conventional Quadruple Therapy in the Treatment of Peptic Ulcer Caused by Helicobacter Pylori Infection[J].Journal of Medical Information,2020,33(09):138.[doi:10.3969/j.issn.1006-1959.2020.02.040]
[9]关 旭,田 桦,卓 越,等.不同疗程布拉氏酵母菌对四联疗法根除Hp的影响[J].医学信息,2020,33(05):144.[doi:10.3969/j.issn.1006-1959.2020.05.046]
　GUAN Xu,TIAN Hua,ZHUO Yue,et al.Effects of Different Courses of Candida Bratella on the Eradication of Hp by Quadruple Therapy[J].Journal of Medical Information,2020,33(09):144.[doi:10.3969/j.issn.1006-1959.2020.05.046]
[10]黄 飞.不同用药方案治疗幽门螺杆菌感染胃溃疡的效果比较[J].医学信息,2020,33(16):156.[doi:10.3969/j.issn.1006-1959.2020.16.050]
　HUANG Fei.Comparison of the Effects of Different Medication Regimens in the Treatment of Gastric Ulcer Infected by Helicobacter Pylori[J].Journal of Medical Information,2020,33(09):156.[doi:10.3969/j.issn.1006-1959.2020.16.050]
[11]王蓓蓓,白 梅.黄芪建中汤加减联合四联疗法对Hp阳性胃溃疡患者Hp清除率及复发率的影响[J].医学信息,2022,35(20):145.[doi:10.3969/j.issn.1006-1959.2022.20.040]
　WANG Bei-bei,BAI Mei.Effect of Huangqi Jianzhong Decoction Combined with Quadruple Therapy on Hp Clearance Rate and Recurrence Rate in Patients with Hp Positive Gastric Ulcer[J].Journal of Medical Information,2022,35(09):145.[doi:10.3969/j.issn.1006-1959.2022.20.040]

更新日期/Last Update: 1900-01-01